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Cip1/WAF1
 
 has cell cycle inhibitory activity by binding
to and inhibiting both cyclin/Cdk kinases and prolif-
erating cell nuclear antigen. Here we show that
p21
 
Cip1/WAF1
 
 is induced in the cytoplasm during the course
of differentiation of chick retinal precursor cells and N1E-115
cells. Ectopic expression of p21
 
Cip1/WAF1
 
 lacking the nuclear
localization signal in N1E-115 cells and NIH3T3 cells affects
the formation of actin structures, characteristic of inactivation
p
 
of Rho. p21
 
Cip1/WAF1
 
 forms a complex with Rho-kinase and
inhibits its activity in vitro and in vivo. Neurite outgrowth
and branching from the hippocampal neurons are promoted
if p21
 
Cip1/WAF1
 
 is expressed abundantly in the cytoplasm.
These results suggest that cytoplasmic p21
 
Cip1/WAF1
 
 may
contribute to the developmental process of the newborn
neurons that extend axons and dendrites into target regions.
 
Introduction
 
A key event during terminal differentiation is a permanent
withdrawal from the cell cycle. Much attention has focused
on regulation of components known to control progression
through the cell cycle, including cyclins, cyclin-dependent
kinase (Cdk)* proteins, and Cdk inhibitors. The p21
 
Cip1/
WAF1
 
 gene was identified through the interaction with Cdk2
(Harper et al., 1993), and its expression is induced by activa-
tion of wild-type p53 (el-Deiry et al., 1993), and during cel-
lular senescence (Noda et al., 1994) and differentiation
(Jiang et al., 1994). An NH
 
2
 
-terminal domain of p21
 
Cip1/
WAF1
 
 inhibits cyclin-Cdk kinases and a COOH-terminal do-
main of p21
 
Cip1/WAF1
 
 inhibits proliferating cell nuclear anti-
gen (Waga et al., 1994; Chen et al., 1995; Luo et al., 1995;
Sherr and Roberts, 1995). These cell cycle inhibitory activi-
ties of p21
 
Cip1/WAF1
 
 are attributable to its nuclear localization
(Goubin and Ducommun, 1995; Sherr and Roberts, 1995).
However, recent studies provide evidence that p21
 
Cip1/WAF1
 
has other biological activities in the cytoplasm. During the
process of monocytic differentiation of U937 cells and
HL60 cells by the treatment with vitamin D3, p21
 
Cip1/WAF1
 
expression was induced in the cytoplasm and this cytoplas-
mic p21
 
Cip1/WAF1
 
 forms a complex with the apoptosis signal-
regulating kinase 1 and inhibits the stress-activated MAPK
cascade, thus contributing to the acquisition of resistance to
various apoptogenic stimuli (Asada et al., 1999). Cytoplas-
mic localization of p21
 
Cip1/WAF1
 
 was also observed in periph-
eral blood monocytes (Asada et al., 1999). Several reports
propose possible mechanisms of translocation of p21
 
Cip1/
WAF1
 
 from the nucleus to the cytoplasm. It is reported that
phosphatidylinositol-3 kinase/Akt phosphorylates threonine
145 in COOH-terminal NLS of p21
 
Cip1/WAF1
 
 and phosphor-
ylated p21
 
Cip1/WAF1
 
 loses its ability to localize in the nucleus
(Zhou et al., 2001). Another paper shows that truncation of
the COOH-terminal of p21
 
Cip1/WAF1
 
 by a member of the
caspase family of proteases results in the loss of its NLS and
the localization changes (Levkau et al., 1998).
During the course of differentiation of the neuronal cells,
p21
 
Cip1/WAF1
 
 also plays important roles in regulating the cell
cycle. In several cell lines during differentiation after nerve
growth factor treatment, the expression of p21
 
Cip1/WAF1
 
 pro-
tein was increased (Decker, 1995; Dobashi et al., 1995; Yan
and Ziff, 1995; Poluha et al., 1996; van Grunsven et al.,
1996; Gollapudi and Neet, 1997; Erhardt and Pittman,
1998). However, neurons after differentiation seem to have
special features, distinct from other cell types, as newborn
neurons extend axons and dendrites to communicate with
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appropriate targets. For example, dorsal root ganglion neu-
rons up to postnatal day 3 to 4 or embryonic retinal
ganglion neurons can extend their neurites rapidly on my-
elin-associated glycoprotein, which is an effective neurite
outgrowth inhibitor for adult neurons (Johnson et al., 1989;
Mukhopadhyay et al., 1994; De Bellard et al., 1996; Cai et
al., 2001). These findings suggest that immature neurons
may have intrinsic mechanisms that confer resistance to the
inhibitory molecules.
Here we show a novel function of cytoplasmic p21
 
Cip1/
WAF1
 
. Cytoplasmic expression of p21
 
Cip1/WAF1
 
 was observed
in newborn neurons that extensively extend neurites. As
p21
 
Cip1/WAF1
 
 binds to Rho-kinase and inhibits its activity,
changes in the cytoskeletal organization are at least partly at-
tributable to the nonenzymatic protein inhibitor.
 
Results
 
Chick retinal neurons from E5 embryos display 
cytoplasmic p21
 
Cip1/WAF1
 
 expression
 
During the period of active neurogenesis, some neuroblasts
enter the postmitotic state and then start migrating to their
final destination. In the embryonic chick retina, ganglion
cells are actively generated around embryonic day 5 (E5)
(Frade et al., 1997). We examined expression of p21
 
Cip1/WAF1
 
in these cells to test whether p21
 
Cip1/WAF1
 
 was associated with
differentiation and morphogenesis of these cells. Using im-
munohistochemistry it was found that retinal neurons im-
mediately after neurogenesis were migrating into deep layers
(Fig. 1 A). p21
 
Cip1/WAF1
 
 immunoreactivity was detected in
the cells at the vitreous surface of the central neural retina
using a monoclonal antibody against p21
 
Cip1/WAF1
 
 (Fig. 1 A).
These p21
 
Cip1/WAF1
 
-positive cells were immature retinal neu-
rons before migration. Therefore, it is suggested that p21
 
Cip1/
WAF1
 
 is involved in the differentiation of retinal precursor
cells in vivo.
Next, we isolated neural precursor cells from E5 retinas to
assess more precisely the subcellular localization of p21
 
Cip1/
WAF1
 
. Dissociated retinal cells cultured on laminin-1 ex-
tended neurites rapidly (Frade et al., 1996b). Cells were cul-
tured on laminin-1 in a chemically defined medium con-
taining 1 
 
 
 
M insulin. Insulin used in the micromolar range
is likely to be acting on insulin-like growth factor-I recep-
tors, thus mimicking the differentiative effect of insulin-like
growth factor-I on the E5 retinal cells (Frade et al., 1996a).
In almost all the immature cells devoid of immunoreactivity
for 
 
 
 
-tubulin, the expression of p21
 
Cip1/WAF1
 
 was predomi-
nantly seen in the nucleus (Fig. 1 B). p21
 
Cip1/WAF1
 
 in the nu-
cleus may contribute to a change in the cell cycle in these
cells. On the other hand, in most neurons that had relatively
long neurites with immunoreactivity for neuron-specific
 
 
 
-tubulin, p21
 
Cip1/WAF1
 
 was mainly localized in the cyto-
plasm (Fig. 1 B). These findings suggest that cytoplasmic ex-
pression of p21
 
Cip1/WAF1
 
 is induced in the newborn neurons.
 
In vitro differentiation of N1E-115 cells is associated 
with p21
 
Cip1/WAF1
 
 expression in the cytoplasm
 
We next used neuroblastoma N1E-115 cells to examine
whether neuronal differentiation was associated with cyto-
Figure 1. Chick retinal neurons from E5 embryos display 
cytoplasmic p21
Cip1/WAF1 expression. (A) Chick retinas from E5 
embryos were immunostained with the anti-p21
Cip1/WAF1 antibody. 
In every panel, the right side is the vitreous body and the left side is 
the pigment epithelium. (B) p21
Cip1/WAF1 immunoreactivity in chick 
dissociated retinal cells from E5 embryos. The top panels are the 
cells devoid of  -tubulin immunoreactivity, and the bottom panels 
are the neurons.
Figure 2.  Subcellular localization of p21
Cip1/WAF1 in DMSO-induced 
differentiating N1E-115 cells. (A–C) Immunocytochemical staining 
of p21
Cip1/WAF1 with the anti-p21
Cip1/WAF1 antibody. Representative 
features of N1E-115 cells incubated without DMSO (A), or with 
DMSO for 1 d (B), and 4 d (C). 
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plasmic expression of p21
 
Cip1/WAF1
 
. N1E-115 cells, which
were induced to differentiate by DMSO, were immu-
nostained with the anti-p21
 
Cip1/WAF1
 
 antibody. After 24 h of
DMSO treatment, p21
 
Cip1/WAF1
 
 was induced in the nucleus
(Fig. 2 B). However, after 4 d, a time point when the exten-
sive neurite genesis was well evident, p21
 
Cip1/WAF1
 
 was mainly
localized in the cytoplasm (Fig. 2 C). In this regard, the dif-
ferentiation-associated cytoplasmic expression of p21
 
Cip1/
WAF1
 
 is not restricted to chick retinal precursor cells.
 
Ectopic expression of p21
 
Cip1/WAF1
 
 affects the 
morphology of N1E-115 cells
 
As the cells with cytoplasmic expression of p21
 
Cip1/WAF1
 
 ex-
tended long neurites, and those devoid of cytoplasmic
p21
 
Cip1/WAF1
 
 did not (Figs. 1 and 2), we hypothesized that
cytoplasmic p21
 
Cip1/WAF1
 
 was associated with neurite elonga-
tion. Therefore, we next asked if relocalization of p21
 
Cip1/
WAF1
 
 to the cytoplasm elicited the extension of the neurites.
To address this question, the mammalian expression vector
for p21
 
Cip1/WAF1
 
 with loss of nuclear localization signal
(
 
 
 
NLS-p21; aa 1–140) as well as the full-length p21
 
Cip1/WAF1
 
(full-p21; aa 1–164) was made (Asada et al., 1999). The cells
transfected with 
 
 
 
NLS-p21 or GFP proliferated until 48 h
after transfection (Fig. 3 A), although those with full-p21
stopped proliferation. In the cells transfected with full-p21
or treated with DMSO, the protein level of cyclin D3
strongly increased (Kranenburg et al., 1995), whereas no
change in the expression was found in those with 
 
 
 
NLS-p21
(Fig. 3 B). Furthermore, although underphosphorylated
pRb, retinoblastoma gene product, was induced and hyper-
phosphorylated pRb became undetectable by DMSO treat-
ment, hyperphosphorylated pRb remained predominant in
 
 
 
NLS-p21–transfected cells during the observation period
(Fig. 3 B). These data demonstrate that 
 
 
 
NLS-p21 has no
differentiation inducing activity in N1E-115 cells, as shown
in U937 cells (Asada et al., 1999), thus enabling us to esti-
mate the effects of p21
 
Cip1/WAF1
 
 without taking the differenti-
ation effect on the cells into account. The expression level of
 
 
 
NLS-p21 in N1E-115 cells was comparable with that of
endogenous p21
 
Cip1/WAF1
 
 in the cells with DMSO treatment
for 4 d (Fig. 3 C). N1E-115 cells were transfected with these
constructs and the morphological changes were assessed 48 h
later. The cells with the full-length p21
 
Cip1/WAF1
 
 expression
showed a somewhat flattened and enlarged appearance and
decreased cell rounding (Fig. 3 D) compared to those with
GFP expression or no transfection, whereas there was no in-
crease in the cell population that had long neurites (Fig. 3
E). These changes may be caused by the differentiation of
N1E-115 cells expressing p21
 
Cip1/WAF1
 
 in the nucleus
(Kranenburg et al., 1995), as we observed a similar pheno-
type when the cells were induced to be differentiated by
DMSO treatment (Kimhi et al., 1976) (unpublished data).
The cells with the full-length p21
 
Cip1/WAF1
 
 expression ex-
tended long neurites 4 d later, a time point when the signal
for p21
 
Cip1/WAF1
 
 was also seen in the cytoplasm (unpublished
data). On the other hand, 
 
 
 
45% of the cells transfected
with 
 
 
 
NLS-p21 extended long neurites (3.1-fold increase
compared with the control; Fig. 3 E). This result suggests
that cytoplasmic p21
 
Cip1/WAF1
 
 regulates neurite remodeling
in N1E-115 cells.
 
Effects of cytoplasmic p21
 
Cip1/WAF1
 
 on the 
cytoskeletal organization
 
Overexpression of a dominant active mutant of RhoA or
p160ROCK, an isoform of Rho-kinase, induced cell round-
ing in N1E-115 cells (Hirose et al., 1998), but the expres-
sion of a dominant negative mutant of p160ROCK or treat-
ment with Y-27632 (Fig. 3 E), chemical compounds with
Figure 3.  Morphological changes of N1E-115 
cells by overexpression of p21
Cip1/WAF1. (A) Growth 
of N1E-115 cells. Cells were seeded in 6-cm 
dishes, transfected, and were counted 1 and 2 d 
after transfection. The relative increases in the 
number of the cells are shown. The values are 
means   SEM of 3 independent experiments. 
*, P   0.01 compared with full-p21 (Student’s t 
test). There is no significant difference between 
GFP and GFP- NLS-p21 transfected cells. (B) 
Western blot analysis of cyclinD3 and pRb. N1E-115 
cells were treated with DMSO, or transfected 
with GFP-full-p21 or GFP- NLS-p21, then were 
harvested at 1, 2, 3 and 4 d. Arrowheads indicate 
hyperphosphorylated pRb, and the arrow indicates 
underphosphorylated pRb. (C) Expression levels of 
p21
Cip1/WAF1 in N1E-115 cells treated with DMSO 
for 4 d or transfected with GFP- NLS-p21. (D) 
N1E-115 cells were transfected with GFP (control), 
GFP-full-p21 or GFP- NLS-p21. Shown are photo-
micrographs of the cells transfected with each 
construct. (E) Quantification of the morphology 
of the cells. N1E-115 cells exposed to Y-27632 
(10  M) for 30 min or expressing GFP, GFP-full-
p21, or GFP- NLS-p21 were categorized into 
three groups; the cells with long neurites (long 
neurite), cells with a round form (round), and cells with other forms (others). Data represent means   SEM of three independent experiments. 
*, P   0.05 compared with control. **, P   0.01 compared with control as well as full-p21 (Student’s t test). 
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specific inhibitory activity of Rho-kinase (Uehata et al.,
1997), induced significant neurite formation (Hirose et al.,
1998). Our findings in N1E-115 cells, in combination with
these previous reports, suggest that the neurite-promoting
activity of cytoplasmic p21
 
Cip1/WAF1
 
 may be associated with
Rho/Rho-kinase. Therefore, we next used NIH3T3 cells to
examine whether p21
 
Cip1/WAF1
 
 would regulate actin cytoskel-
eton mediated by Rho. NIH3T3 cells were transfected with
 
 
 
NLS-p21, and then were serum-starved for 16 h. Incuba-
tion with serum for 10 min induced the formation of actin
stress fibers, preferentially through activation of Rho (Ridley
and Hall, 1992). However, NIH3T3 cells transfected with
 
 
 
NLS-p21 had little stress fiber formation after the addition
of serum, whereas prominent stress fibers were found in
nontransfected cells (Fig. 4, A and B). Extensive actin stress
fibers were observed in the cells with the full-length p21
 
Cip1/
WAF1
 
 expression (unpublished data). These results suggest
that Rho-induced actin reorganization in NIH3T3 cells may
be blocked by the cytoplasmic expression of p21
 
Cip1/WAF1
 
.
 
p21
 
Cip1/WAF1
 
 binds to Rho-kinase in the cytoplasm
 
Rho-kinase was shown to work with mDia1 to elicit the
Rho induced phenotype in the fibroblast (Watanabe et al.,
1999). As the serum is one of the most potent activators of
Rho (Ridley and Hall, 1992), loss of stress fiber formation
by the expression of cytoplasmic p21
 
Cip1/WAF1
 
 in serum stim-
ulated cells may result from the blockade of the down-
stream pathway of Rho. Morphological changes of N1E-
115 cells by the expression of 
 
 
 
NLS-p21 were comparable
with those by Y-27632 (Fig. 3 E). Given that p21
 
Cip1/WAF1
 
inhibits the activity of the apoptosis signal-regulating kinase
1 (Asada et al., 1999) as well as cyclin-Cdk kinases that are
serine threonine kinases (for review see Pines, 1995), we
speculated that p21
 
Cip1/WAF1
 
 might inhibit the activity of
Rho-kinase, which is also a serine threonine kinase. To test
the possibility that cytoplasmic p21
Cip1/WAF1 forms a com-
plex with Rho-kinase in the cytoplasm, coimmunoprecipi-
tation studies were performed using the 293T cells cotrans-
fected with GFP- NLS-p21 and myc-tagged Rho-kinase.
Cytoplasmic expression was well evident in the 293T cells
transfected with GFP- NLS-p21 (Fig. 5 A). When the ly-
sates were immunoprecipitated with the anti-p21
Cip1/WAF1
antibody, p21
Cip1/WAF1 efficiently precipitated myc-tagged
Rho-kinase (Fig. 5 B). In an attempt to test if the interac-
tion of  NLS-p21 with Rho-kinase depends on its cellular
Figure 4.  Effects of cytoplasmic p21
Cip1/WAF1 on the cytoskeletal 
organization. (A) NIH3T3 cells were transfected with GFP- NLS-p21. 
After serum starvation for 16 h, the cells were treated with 10% fetal 
bovine serum, fixed, and stained with rhodamine-conjugated 
phalloidine. (B) Quantification of the cells containing stress fibers. 
Data represent means   SEM of three independent experiments. 
*, P   0.01 compared with GFP (Student’s t test).
Figure 5.  Cytoplasmic p21
Cip1/WAF1, but not 
p21
Cip1/WAF1 in the nucleus, precipitates Rho-kinase. 
(A) Subcellular localization of ectopically expressed 
proteins in 293T cells. Note the difference in the 
localization between GFP-full-p21 and GFP- NLS-
p21. (B) 293T cells were cotransfected with 
myc-Rho-kinase in combination with GFP-full-p21 
or GFP- NLS-p21. The lysates were immunoprecip-
itated with the anti-p21
Cip1/WAF1 antibody. Immuno-
complexes were electrophoresed and blotted with 
anti-myc antibody. Expression of Rho-kinase and 
p21
Cip1/WAF1 in the lysates was determined. (C) 
Interaction of p21
Cip1/WAF1 with Rho-kinase using 
lysates prepared from differentiating N1E-115 
cells with DMSO treatment. Immunoprecipitated 
p21
Cip1/WAF1 was electrophoresed and immunoblotted 
with anti-Rho-kinase antibody. Anti–mouse IgG 
antibody was used as a negative control. (D) In vitro 
interaction of recombinant full-length p21
Cip1/WAF1 
and the catalytic domain of Rho-kinase (GST-CAT). 
S6 kinase substrate peptide (AKRRRLSSLRA) and 
Y-27632 at the indicated concentrations were 
coincubated. Neurite outgrowth by cytoplasmic p21Cip1/WAF1 | Tanaka et al. 325
localization, we then tested the interaction of Rho-kinase
with GFP-full-p21, which was expressed predominantly in
the nucleus (Fig. 5 A). In contrast to  NLS-p21, only a
faint signal could be detected (Fig. 5 B), despite comparable
expression of the full-length and truncated forms of p21
Cip1/
WAF1 in the 293T cells.
Interaction of the proteins artificially overexpressed may
be difficult to detect in natural cells. Employing the anti-
p21 antibody, we examined the interaction of endogenous
proteins using lysates prepared from differentiating N1E-
115 cells. N1E-115 cells expressed p21
Cip1/WAF1 in the cyto-
plasm after treatment with DMSO for 3 to 4 d (Fig. 2). In
the p21 immunoprecipitates, the anti Rho-kinase antibody
revealed the presence of a protein corresponding to Rho-kinase
(Fig. 5 C).
The lack of an interaction of the full-length-p21 with
Rho-kinase may be attributable to the difference of the local-
ization in the cells. Therefore, we tested the in vitro interac-
tion of the recombinant full-length p21
Cip1/WAF1 and Rho-kinase.
These proteins in vitro bound to each other (Fig. 5 D). As
GST fused to the fragment of Rho kinase used here corre-
sponds to the catalytic region of Rho-kinase (GST–CAT; aa
6–553), p21
Cip1/WAF1 may directly bind to the catalytic re-
gion of Rho-kinase. This is substantiated by our finding that
S6 kinase substrate peptide (AKRRRLSSLRA) as well as
Y-27632 inhibited the interaction of p21
Cip1/WAF1 with Rho-
kinase dose dependently (Fig. 5 D). These results suggest that
p21
Cip1/WAF1 associates with Rho-kinase in the cytoplasm.
p21
Cip1/WAF1 inhibits Rho-kinase activity
We next investigated whether p21
Cip1/WAF1 could inhibit the
activity of Rho-kinase in vitro. The kinase assay was carried
out using S6 kinase substrate peptide and [ -
32P] ATP. By
using a scintillation counter, the quantity of 
32P-labeled sub-
strate peptide on the phosphocellulose paper was deter-
mined. This kinetic analysis revealed that p21
Cip1/WAF1 inhib-
ited the Rho-kinase activity toward S6 kinase substrate
peptide in a dose-dependent manner (Fig. 6 A), and the IC50
value estimated was 1.43 nM.
These results prompted us to examine whether the Rho-
kinase activity was inhibited by the expression of  NLS-p21
in vivo. 293T cells were transfected with myc-Rho-kinase
with or without  NLS-p21. The kinase assay was carried
out using the lysates from the cells in the same method as
the in vitro assay. The results show that the Rho-kinase ac-
tivity was inhibited to 48.1% on average in the cells express-
ing  NLS-p21 compared with the control (Fig. 6 B). This
inhibitory effect was comparable with that of Y-27632
(51.9% inhibition), although expression of the full-length
p21
Cip1/WAF1 had no significant effect. Our data clearly dem-
onstrate that the activity of Rho-kinase was inhibited by
p21
Cip1/WAF1 in vivo as well as in vitro.
Cytoplasmic p21
Cip1/WAF1 promotes neurite outgrowth 
and branching of the hippocampal neurons
To investigate the relevance of our findings that the cyto-
plasmic p21
Cip1/WAF1 acts on Rho-kinase, we assessed the ef-
fects on neurons. Cultures of the hippocampal neurons from
rat E18 embryos were used. We chose these neurons, as they
did not express endogenous p21
Cip1/WAF1 enough to be de-
tected by immunocytochemistry using the anti-p21
Cip1/WAF1
antibody (unpublished data). Dissociated hippocampal neu-
rons were incubated for 48 h and transfected with  NLS-
p21. 24 h after transfection, the cells were fixed and immu-
nolabeled with  -tubulin III. The total neurite length per
neuron, the axonal length, defined as the length of the long-
est neurite per neuron, the number of primary processes
originating from the neuronal somata, and the number of
branch points per neuron were determined (Neumann et al.,
2002). The neuronal morphology of the cells expressing
 NLS-p21 was apparently different from the control cells
without transfection or expressing GFP (Fig. 7 A). The cells
with the  NLS-p21 expression extended longer neurites and
had more branch points than the control cells (GFP-express-
ing cells or no transfection). Ectopic expression of  NLS-
p21 increased the total neurite length per neuron from
135.9   m ( 7.2   m SEM) to 307.2  m ( 34.0   m
SEM), the axonal length from 66.3  m ( 3.2  m SEM) to
162.9  m ( 18.6  m SEM), and the number of branch
points per neuron from 1.3 ( 0.2 SEM) to 2.6 ( 0.3
SEM). However, no change in the number of primary pro-
cesses was found by overexpression of cytoplasmic p21
Cip1/
WAF1 (Fig. 7 B). These results indicate that cytoplasmic
p21
Cip1/WAF1 regulates neurite remodeling in the embryonic
hippocampal neurons.
Figure 6.  p21
Cip1/WAF1 inhibits Rho-kinase activity. (A) The activity 
of Rho-kinase was assayed in the presence of the indicated concen-
trations of p21
Cip1/WAF1. The percentage was quantified compared to 
CPM in the absence of p21
Cip1/WAF1. Data represent means   SEM of 
three independent experiments. (B) The activity of Rho-kinase was 
assayed with the cells exposed to Y-27632 (10  M) for 30 min or 
cotransfected with myc-Rho-kinase and p21
Cip1/WAF1 constructs. 
The expression of Rho-kinase was determined by Western blot to 
normalize the relative activities. The relative activities were quantified 
compared to CPM in the control cells cotransfected with myc-Rho-
kinase and GFP. Data represent means   SEM of 3 independent 
experiments. *, P   0.001 compared with control (Student’s t test).326 The Journal of Cell Biology | Volume 158, Number 2, 2002
Discussion
In the developmental stage of chick retina, p21
Cip1/WAF1 was
shown to be associated with the differentiation of the neu-
rons. The newborn neurons from E5 chick neural retina in
vitro and differentiating N1E-115 cells express p21
Cip1/WAF1
in the cytoplasm. Ectopic expression of p21
Cip1/WAF1 without
the NLS suppresses stress fiber formation in the serum-stim-
ulated NIH3T3 cells and promotes neurite outgrowth from
N1E-115 cells and E18 hippocampal neurons. These effects
may be mediated by the inhibition of Rho-kinase, as p21
Cip1/
WAF1 inhibits Rho-kinase activity in vitro and in vivo.
Cytoplasmic expression of p21
Cip1/WAF1
There have been several reports that show cytoplasmic ex-
pression of p21
Cip1/WAF1 and its possible mechanisms. In pe-
ripheral blood monocytes and differentiating U937 cells,
p21
Cip1/WAF1 was detected in the cytoplasm (Lubbert et al.,
1991; Asada et al., 1999). U937 cells can differentiate into
monocytes with vitamin D3 treatment, and 1 d after the
treatment p21
Cip1/WAF1 was induced in the nucleus. How-
ever, it was mainly localized in the cytoplasm after 3 d, a
time point when the monocytic differentiation was well ev-
ident. As we noticed that young neurons which express
 -tubulin display cytoplasmic p21
Cip1/WAF1 expression, whereas
the precursor cells not expressing  -tubulin did not (Fig. 1
B), it is suggested that cytoplasmic p21
Cip1/WAF1 is induced
during the developmental stage after differentiation in neu-
rons as well as monocytic cells and has relevant roles.
Zhou et al. (2001) previously reported a possible mecha-
nism of translocation of p21
Cip1/WAF1, which was triggered by
Akt-induced phosphorylation of p21
Cip1/WAF1 at residues
Thr
145. As Thr
145 is in the NLS of p21
Cip1/WAF1, phosphoryla-
tion of p21
Cip1/WAF1 may result in the loss of its nuclear local-
ization ability. However, another group casts doubt on this
finding, as they could not confirm translocation of p21
Cip1/
WAF1 by this phosphorylation (Rossig et al., 2001). More in-
vestigation will be required to address this discrepancy;
therefore, we did not use the constitutive phosphorylated
mutant of p21
Cip1/WAF1 in our study. Truncation of the nu-
clear localization signal is also the mechanism of regulation
of subcellular localization of p21
Cip1/WAF1. At an early phase
during DNA damage-induced apoptosis, the COOH-termi-
nal of p21
Cip1/WAF1 is truncated by a member of the caspase
family of proteases (Gervais et al., 1998; Levkau et al., 1998;
Zhang et al., 1999), and after cleavage p21
Cip1/WAF1 loses its
NLS and exits from the nucleus (Levkau et al., 1998). The
 NLS-p21 construct we used here was similar to this trun-
cated p21
Cip1/WAF1 and worked well in our system. However,
as we observed the signals for GFP- NLS-p21 also in the
nucleus of transfected cells and the hippocampal neurons,
GFP- NLS-p21 would enter the nucleus by passive diffu-
sion (Lang et al., 1986).
Cytoplasmic p21
Cip1/WAF1 inhibits Rho-kinase activity
Rho-kinase plays important roles in, for example, stress fi-
ber, and focal adhesion formation (Leung et al., 1996;
Amano et al., 1997), smooth muscle contraction (Kureishi
et al., 1997), cytokinesis (Yasui et al., 1998), and neurite
retraction (Amano et al., 1998), as a downstream effector
of Rho (Matsui et al., 1996). Some chemical compounds
have been shown to inhibit Rho-kinase activity (Uehata et
al., 1997). Staurosporine, HA1077 and Y-32885 inhibited
the activity of Rho-kinase as well as protein kinase N, one
of the targets of Rho, and the IC50 values of these toward
Rho-kinase were  7 nM, 1.7  M, and 0.4  M, respec-
tively (Amano et al., 1999). In this study, p21
Cip1/WAF1 in-
hibited Rho-kinase activity in a dose-dependent manner,
and the IC50 value was 1.43 nM, suggesting the strong in-
hibitory effect.
Rho/Rho-kinase and the neurite outgrowth
A number of factors that regulate Rho activity are implicated
in neurite outgrowth and growth cone guidance (for review see
Luo, 2000). We showed previously that the axonal outgrowth
was facilitated by the ligand binding to the neurotrophin re-
ceptor p75 presumably through inactivation of Rho (Yama-
shita et al., 1999). In addition, our observation that myelin-asso-
ciated glycoprotein as well as tumor necrosis factor elicited
inhibition of neurite outgrowth and branching seems to be
mediated by the activation of Rho (Neumann et al., 2002; Ya-
Figure 7.  Neurite outgrowth and branching of hippocampal 
neurons by overexpression of cytoplasmic p21
Cip1/WAF1. (A) 
Morphology of hippocampal neurons transfected with GFP or 
GFP- NLS-p21 by computer tracing. Primary hippocampal neurons 
were transfected with GFP (control) or GFP- NLS-p21 ( NLS-p21). 
Neurons were immunostained with anti– -tubulin III antibody, and 
were traced with image analysis computer software. Bars, 10  m. (B) 
Morphological analysis of primary hippocampal neurons transfected 
with GFP or GFP- NLS-p21. In neurons transfected with  NLS-p21, 
the total neurite length, the axonal length and the number of branch 
points per neuron were increased compared with those transfected 
with GFP. Data represent means   SEM of three independent 
experiments. *, P   0.001 compared with control (Student’s t test). Neurite outgrowth by cytoplasmic p21Cip1/WAF1 | Tanaka et al. 327
mashita et al., 2002). Taking these findings into consideration,
blocking the activity of Rho-kinase would be a good molecular
target, as the axonal outgrowth should be promoted by block-
ing the downstream pathway even if Rho is activated by some
cytokines or guidance molecules. In fact, Rho-kinase was
shown to be a possible therapeutic target for central nervous
system axon regeneration (Lehmann et al., 1999).
However, not all the neuronal cells respond to various
stimuli in the same way. In PC12 cells during differentiation
after nerve growth factor treatment, ectopic expression of
constitutively active Rho does not cause the disappearance of
neurites (Sebok et al., 1999). In dorsal root ganglion neu-
rons up to postnatal day 3 to 4 or embryonic retinal gan-
glion neurons, axonal outgrowth was not significantly inhib-
ited by myelin-associated glycoprotein, which activates Rho
(Johnson et al., 1989; Mukhopadhyay et al., 1994; De Bel-
lard et al., 1996; Cai et al., 2001; Yamashita et al., 2002).
Although these reports suggest that the responses of the neu-
rons to Rho depend on the cell context, another interpreta-
tion of the data is that immature or young neurons may have
intrinsic mechanisms to overcome the inhibitory effects me-
diated by Rho. The molecular mechanisms that govern these
phenomenon remain to be elucidated, however, our notion
that cytoplasmic p21
Cip1/WAF1 promotes neurite outgrowth
through inactivation of Rho-kinase may be an interesting
hypothesis to explain the loss of responses to Rho activation.
Future studies will address these issues.
Materials and methods
Preparation of chick retina and retinal cells
Whole chick E5 embryos (White Leghorn) were fixed with 4% paraformal-
dehyde in PBS overnight and immersed in 30% sucrose. Cryosections (30
 m in thickness) of retinas were cut on the coronal plane, thaw mounted
onto slides, and dried at room temperature. For retinal neuron culture, reti-
nas from E5 embryos were dissected free from the pigment epithelium and
dissociated as described previously (Rodriguez-Tebar et al., 1989; de la
Rosa et al., 1994). Dissociated cells were plated (20,000 cells/cm
2) on 4-well
chamber slides (Nalge Nunc International K.K.), which were previously
coated with poly-L-ornithine/laminin (Sigma-Aldrich) (Collins, 1978). Cells
were cultured in DME/F12 mixture (1:1) with N2 supplement (Bottenstein
and Sato, 1979), and maintained at 37 C in a water-saturated atmosphere
containing 5% CO2 for 12 h and fixed with 4% paraformaldehyde in PBS.
Plasmid constructs
pEGFP-full-p21 (aa 1–164) and pEGFP- NLS-p21 (aa 1–140) are mamma-
lian expression vectors for GFP fused proteins (Asada et al., 1999). Myc-
Rho-kinase in pEF-BOS was provided by Dr. K. Kaibuchi (Nagoya Univer-
sity, Nagoya, Japan).
Cell culture and transfection
NIH3T3 cells, N1E-115 cells, and 293T cells were maintained in DME con-
taining 10% fetal bovine serum. Lipofectamine 2000 (Invitrogen) was used
for transfection. For the stress fiber formation assay, NIH3T3 cells were cul-
tured in serum-free medium for 16 h after transfection. Stress fiber formation
was evoked by incubating the cells with 10% serum for 10 min. Hippocam-
pal neurons were prepared from 18-d-old Sprague-Dawley rats, as previ-
ously described (Neumann et al., 1995). Briefly, hippocampi were dissected
and the meninges removed. The trimmed tissue was dissociated by tritura-
tion. The dissociated cells were plated on dishes precoated with poly-L-lysine
(Sigma-Aldrich), and cultured in DME containing 10% fetal bovine serum for
24 h. Then, the medium was replaced with DME with B27 supplement (In-
vitrogen), and the cells were transfected with GFP or GFP- NLS-p21. Neu-
ronal morphology was estimated at 24 h after the transfection.
Morphological analysis of N1E-115 cells
N1E-115 cells were transfected with GFP, GFP-full-p21, or GFP- NLS-
p21, and cultured in serum-starved condition for 5 h. Then, the medium
was replaced with DME containing 10% fetal bovine serum. The cells
were fixed at 48 h after transfection. The morphology of the cells was cate-
gorized into three groups; neurite-positive cells, round cells, and the other
cells. The cells with longer neurites than their soma were defined as neu-
rite positive cells. The other cells had various features including mi-
crospikes, ruffles and a flattened appearance.
Coimmunoprecipitation of  NLS-p21 and Rho-kinase
293T cells were transfected with myc-Rho-kinase in combination with
GFP-full-p21 or GFP- NLS-p21. At 48 h after transfection, the cells were
lysed with 1 ml of lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl,
10% glycerol, 0.5% Nonidet-P40 including protease inhibitor cocktail
tablets; Roche). The cell lysates were centrifuged at 13,000 g for 20 min,
and the supernatant was collected. Immunoprecipitations were per-
formed for 2 h at 4 C using an anti-p21
Cip1/WAF1 mouse monoclonal anti-
body (Santa Cruz Biotechnology) and 0.75 ml of the supernatant. The im-
munocomplexes were collected with protein G-Sepharose (Amersham
Pharmacia Biotech) slurry (50% vol/vol), washed four times with lysis
buffer, and subjected to SDS-PAGE. They were transferred to the polyvi-
nylidene difluoride membranes and probed with the anti-myc rabbit
polyclonal antibody (Santa Cruz Biotechnology). Interaction of endoge-
nous proteins in N1E-115 cells was assessed in the same way using anti–
Rho-kinase antibody.
In vitro binding assay
Recombinant full-length p21
Cip1/WAF1 (1–164,  98% purity, 1 nM; Santa
Cruz Biotechnology) and purified GST fused protein of a fragment of Rho-
kinase (GST-CAT; aa 6–553) were incubated in 1 ml of the buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 1 mM
EDTA including protease inhibitor cocktail tablets) for 2 h, and GST-CAT
was precipitated using glutathione sepharose (Amersham Pharmacia Bio-
tech). The resultant precipitates were electrophoretically transferred to
polyvinylidene difluoride membranes after SDS/PAGE with 10% gels and
were immunoblotted with the anti-p21
Cip1/WAF1 antibody.
Kinase assay
The kinase reaction for Rho-kinase was carried out using a S6 Kinase As-
say Kit (Upstate Biotechnology) according to the manufacturer’s instruc-
tions. Briefly, for in vitro assay, 10  l of assay dilution buffer (ADB: 20
mM MOPS, pH 7.2, 25 mM  -glycerol phosphate, 5 mM EGTA, 1 mM
sodium orthovanadate and 1 mM dithiothreitol), 10  l of substrate cock-
tail (250  M substrate peptide [AKRRRLSSLRA] in ADB), 10  l of the in-
hibitor cocktail, 10  l of the [ -
32P] ATP mixture (magnesium/ATP cock-
tail including 10  Ci of the [ -
32P] ATP) and 20 mU of Rho kinase
fragment (aa 1–543; Upstate Biotechnology) were mixed. After incuba-
tion with p21
Cip1/WAF1 protein for 10 min at 30 C, the reaction mixtures
were spotted onto the P81 phosphocellulose paper and quantified using
a scintillation counter.
For the in vivo assay, 293T cells were cotransfected with myc-Rho-
kinase in combination with GFP or p21
Cip1/WAF1 constructs. Cells were lysed
with lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10% glycerol,
1% Nonidet-P40 and protease inhibitor cocktail). The kinase assay was
carried out using the lysates.
Immunostaining
For immunohistochemistry, sections of chick retinas were permeabilized
and blocked with the blocking buffer (0.1% Triton X-100, 0.1% BSA, and
5% goat serum in PBS) for 30 min at room temperature. For immunocy-
tochemistry, cells were permeabilized and blocked with the buffer con-
taining 0.2% Triton X-100. They were incubated overnight at 4 C with the
anti-p21
Cip1/WAF1 antibody (1:1000) and an anti– -tubulin class III rabbit
polyclonal antibody (TuJ1) (1:2,000; Research Diagnostic, Inc.), followed
by incubation for 1 hour with Alexa 488-labeled goat anti–mouse IgG anti-
body (Molecular Probes) and Alexa 568-labeled goat anti–rabbit IgG anti-
body (Molecular Probes). Tetramethyl rhodamine isothiocyanate-labeled
phalloidin (1:1,000; Sigma-Aldrich) was used to detect F-actin in NIH3T3
cells and N1E-115 cells. Hippocampal neurons were immunostained with
the anti-TuJ1 antibody. When necessary, DAPI (300 nM; Wako) was used
to stain the nucleus. Samples were examined under a confocal laser-scan-
ning microscope (Carl Zeiss).
Y-27632 was a gift of Mitsubishi Pharma Corporation.
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